MUCUS RELIEF - guaifenesin tablet, extended release 
Major Pharmaceuticals

----------

MUCUS RELIEF
Guaifenesin Extended-Release Tablets 600 mg

ACTIVE INGREDIENT(in each extended-release tablet)

Guaifenesin 600 mg

PURPOSE

Expectorant

USE(S)

helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive

WARNING

.

DO NOT USE

for children under 12 years of age

ASK A DOCTOR BEFORE USE IF YOU HAVE

STOP USE AND ASK A DOCTOR IF

IF PREGNANT OR BREAST-FEEDING,

ask a health professional before use.

KEEP OUT OF REACH OF CHILDREN

In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).

DIRECTIONS

OTHER INFORMATION

INACTIVE INGREDIENTS

carbomer homopolymer, hypromellose, microcrystalline cellulose, povidone

QUESTIONS?

1-800-616-2471

You may also report side effects to this phone number. 

PRINCIPAL DISPLAY PANEL

MAJOR®
NDC 0904-6986-40
Compare to the active ingredient in Mucinex® Extended Release 600 mg Tablets* 


MUCUS RELIEF 

Guaifenesin Extended-Release Tablets, 600 mg

EXPECTORANT
12 HOUR

Relieves Chest Congestion

Thins and Loosens Mucus

500 EXTENDED-RELEASE TABLETS


35

MUCUS RELIEF 
guaifenesin tablet, extended release
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:0904-6986
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
GUAIFENESIN (UNII: 495W7451VQ) (GUAIFENESIN - UNII:495W7451VQ) GUAIFENESIN600 mg
Inactive Ingredients
Ingredient NameStrength
CARBOMER HOMOPOLYMER, UNSPECIFIED TYPE (UNII: 0A5MM307FC)  
HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO)  
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
POVIDONE, UNSPECIFIED (UNII: FZ989GH94E)  
Product Characteristics
ColorWHITEScoreno score
ShapeCAPSULESize22mm
FlavorImprint Code G233
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0904-6986-40500 in 1 BOTTLE; Type 0: Not a Combination Product09/23/2019
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
ANDAANDA20921509/23/2019
Labeler - Major Pharmaceuticals (191427277)

Revised: 1/2022
Document Id: 1a5eb713-5acb-4e0e-89a8-eae3e9c2841e
Set id: 4d98920b-caf7-42d9-bd08-859d27b6d76a
Version: 4
Effective Time: 20220105
 
Major Pharmaceuticals